PreprintAll rights reservedbioRxiv
ROCK inhibitor Ripasudil reduces Alzheimer pathological proteins and enhances cellular bioenergetics
- 1Boston University
Related
- Interferon-induced transmembrane protein 3 (IFITM3) as a neuroimmune regulator in Alzheimer’s disease: emerging roles in astrocyte activation and pathological signaling
- Design of readers for pathological PTM proteoforms in Alzheimer's disease
- Drosophila Appl loss disrupts proteins in mitochondrial oxidative and glycosylation pathways conserved in Alzheimer's disease
- Astrocytic mitochondria restore neuronal bioenergetics and function in Parkinson disease models
- The Metabolic Organ Clock: A Computable Framework Linking Cell-Lineage Architecture to Emergent Organ Bioenergetics
BibTeX
@misc{li2026rock,
title = {{ROCK inhibitor Ripasudil reduces Alzheimer pathological proteins and enhances cellular bioenergetics}},
author = {Y. Li and Z. Liu and X. Cambi and J. Peterson and G. Benavides and X. Ouyang and A. Candib and J. Zaia and V. Darley-Usmar and C. Zheng and J. Zhang and W. Xia},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.02.761117},
url = {https://www.biorxiv.org/content/10.64898/2026.11.02.761117v1},
}
RIS
TY - UNPB
TI - ROCK inhibitor Ripasudil reduces Alzheimer pathological proteins and enhances cellular bioenergetics
AU - Y. Li
AU - Z. Liu
AU - X. Cambi
AU - J. Peterson
AU - G. Benavides
AU - X. Ouyang
AU - A. Candib
AU - J. Zaia
AU - V. Darley-Usmar
AU - C. Zheng
AU - J. Zhang
AU - W. Xia
PY - 2026
DA - 2026/11/02
PB - bioRxiv
DO - 10.64898/2026.11.02.761117
UR - https://www.biorxiv.org/content/10.64898/2026.11.02.761117v1
ER -